TrialCardiovascular & hematological agents in medicinal chemistry2026
Comparative Efficacy and Safety of Dabigatran, Enoxaparin, and Rivaroxaban for Prophylaxis of Cancer-associated Venous Thromboembolism: A Single-center Randomized Trial.
Pouya Yousefli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.